SIRT1 as a regulator of health and lifespan of mammals
SIRT1 as a regulator of health and lifespan of mammals
批准号:
9101926
负责人:
DAVID A. SINCLAIR
金额:
$42.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2017-02-28
关键词:
AdultAgeAgingAnimalsApoptoticAreaAutophagocytosisBacteriaBiologyBlood CirculationCaenorhabditis elegansCaloric RestrictionCell Culture TechniquesCellsCognitionCommunicationComplementComplement component C1ComplexDNA Repair GeneDefectDependenceDietDiseaseDisease modelDistantDrosophila genusElderlyElectron TransportEnergy MetabolismEnsureFailureFamilyFastingFatty AcidsGenesGeneticGenomeHealthHealth BenefitHeart failureHumanHuman GenomeHypoxiaKnockout MiceLeadLifeLongevityMammalsMediatingMemoryMetabolicMetabolismMethodsMitochondriaMitochondrial DiseasesModelingMolecularMotorMusMuscleMuscle MitochondriaMuscular AtrophyNerve DegenerationNon-Insulin-Dependent Diabetes MellitusNormal tissue morphologyNuclearOrganOrganismPathway interactionsPlayProcessReactive Oxygen SpeciesRegulationRespirationRoleSignal PathwaySignal TransductionSirtuinsSkeletal MuscleSystemTestingTherapeutic InterventionTimeTissuesTransgenic MiceWild Type MouseYeastsage effectage relatedagedbasecell typecofactorcognitive abilitycombatdesigngenetic approachglucose metabolisminsightmitochondrial dysfunctionmitochondrial genomenormal agingnoveloverexpressionplant fungiprotein foldingresearch studyresponsesmall moleculestoichiometryyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Sirtuins are a family of NAD+-dependent deacetylases that are thought to have evolved to increase an organism's chances of surviving adversity. They are found in bacteria, fungi, plants and animals. In mammals, sirtuins are implicated in mediating many of the health benefits of calorie restriction (CR). There are seven mammalian sirtuins, SIRT1-7. SIRT1 is the best studied. Major processes controlled by SIRT1 include DNA repair, protein folding, fatty acid and glucose metabolism, hypoxic responses, autophagy, and anti-apoptotic mechanisms. Over expression of SIRT1 protects mice in a variety of common age-related disease models. Our cells contain two genomes, the nuclear and the mitochondrial. These must be tightly co-regulated to ensure normal tissue function. How this is achieved, and whether this has relevance to aging, is poorly understood. Our unpublished studies indicate that when SIRT1 is deleted in young adult mice, the normal transcriptional synchrony between the two genomes is disrupted, leading to loss of electron transport chain (ETC) stoichiometry, reduced respiration and ATP, increased reactive oxygen species (ROS) and lactate, and a failure of muscle mitochondria to adapt their metabolism to fasting. Strikingly,
this same defect occurs in wild type mice as they age. Thus, loss of genome synchrony may be an underlying, and potentially reversible, cause of normal aging. We have traced the likely cause of the defect to a novel SIRT1-mediated pathway that does not involve the canonical factors PGC- 1�/� or NRF1/2. Aim 1 of this proposal will investigate the mechanisms by which SIRT1 maintains genome synchrony and ETC stoichiometry in skeletal muscle, independent of the canonical PGC- 1�/� pathway. This will provide new and fundamental mechanistic insights into (i) how mitochondria are regulated in response to diet and (ii) how genome synchrony is lost over time. Aim 2 uses novel genetic and pharmacological approaches to restore genome synchrony in aged mice to test whether any of the deleterious effects of aging in highly energetic organs and tissues can be reversed by assessing metabolism, motor function, and cognition. Recent evidence from C. elegans and Drosophila indicates that alterations in mitochondrial function in one cell type (e.g. disrupting the ETC) can extend lifespan by inducing the secretion of putative "mitokines". Because so little is known about how mitochondria communicate within the cell or with other tissues, and its potential role in mammalian aging, Aim 3 will investigate these fundamental processes, in part, by taking advantage of our screen of the human genome that has identified 98 new mitochondrial regulators. Relevance Because of our evolutionary origins, our cells contains two genomes. We find that communication between them breaks down during aging. By understanding how the two genomes communicate -- between each other and potentially to other cells in the body -- the study could lead to new practical strategies for combating rare mitochondrial diseases and common diseases of aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using cellular co-biosis and age programmable mice to derive a global interaction map of aging hallmarks
-
批准号:10721454
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2023
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Tagmentation-based Indexing for Methylation Sequencing as a novel method of high-throughput methylation clock measurement
-
批准号:10273233
-
项目类别:
-
资助金额:$62.63万
-
财政年份:2021
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Nicotinamide Mononucleotide (NMN) as a Novel Therapeutic in the Treatment of Oral Mucositis
-
批准号:9770831
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2018
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Uncovering the Human Secretome
-
批准号:9344966
-
项目类别:
-
资助金额:$118.65万
-
财政年份:2017
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Uncovering the Human Secretome
-
批准号:10223179
-
项目类别:
-
资助金额:$118.65万
-
财政年份:2017
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Uncovering the Human Secretome
-
批准号:9751141
-
项目类别:
-
资助金额:$118.65万
-
财政年份:2017
-
负责人:DAVID A. SINCLAIR
-
依托单位:
Elucidating mechanisms of SIRT1 activation
-
批准号:9315825
-
项目类别:
-
资助金额:$50.83万
-
财政年份:2016
-
负责人:DAVID A. SINCLAIR
-
依托单位:
2009 Biology of Aging Gordon Research Conference
-
批准号:7613586
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2008
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7383794
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:8048190
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7589667
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7260016
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:9268167
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:10116232
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:9884526
-
项目类别:
-
资助金额:$40.01万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:8723013
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:8534005
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT as a regulator of health and lifespan of mammals
-
批准号:7797997
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
SIRT1 as a regulator of health and lifespan of mammals
-
批准号:8387561
-
项目类别:
-
资助金额:$43.24万
-
财政年份:2007
-
负责人:DAVID A. SINCLAIR
-
依托单位:
THE BIOLOGY AND UTILITY SIRT1- MEDIATED NEUROPROTECTION
-
批准号:7085094
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2006
-
负责人:DAVID A. SINCLAIR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: